Toxins A and B are the main virulence factors of Clostridium difficile and are the targets for 20 molecular diagnostic tests. Here we describe a new A-B+CDT-toxinotype (XXXII) 21 characterized by a variant type of pathogenicity locus (PaLoc) without tcdA and with an 22 atypical organization of PaLoc integration site. 23
Clostridium difficile is the main cause of community and nosocomial diarrhea 25 associated to antibiotic treatment and has great healthcare and economic impact (1-3). 26
Three toxins, toxin A (TcdA, enterotoxin), toxin B (TcdB, cytotoxin) and binary toxin 27 CDT, are produced by C. difficile. The latter is present only in a subset of strains, and its role 28 in pathogenesis is increasingly recognized but still unclear (4) . Toxins A and B are the main 29 virulence factors causing damage to intestinal epithelium, producing diarrhea and 30 inflammation, and are also a main target for enzyme-based or molecular diagnostic tests (5, 31 6). Genes encoding TcdA and TcdB are located on the chromosome and together with a 32 three additional genes (tcdR, tcdE and tcdC) form a 19.6 kb pathogenicity locus (PaLoc). The 33 genes for CDT toxin are located elsewhere on the chromosome (CdtLoc). 34 C. difficile strains can be differentiated based on different patterns of toxin 35 production. Strains which do not produce any of the toxins are non-toxinogenic and do not 36 cause disease. The majority of toxigenic strains produce both toxins, TcdA and TcdB (A+B+), 37 but some strains produce only TcdB (A-B+). Toxigenic strains can be also further 38 differentiated into toxinotypes based on changes (deletions, insertions, SNPs) in the PaLoc. 6) GeneXpert C. diff (Cepheid, California, USA) was then performed and results for toxigenic 59 C. difficile was negative. 60
As his condition was considered as non urgent, the patient was discharged with a diagnosis 61 of subacute diarrhea and it was arranged that he be controlled by the digestive medicine 62 department as an outpatient. 63
On the next day, the direct stool cell culture cytotoxicity neutralization assay was positive 64 and after 48 hours of incubation of feces in CLO agar (bioMérieux, Marcy l'Etoile, France) C. 65 on August 15, 2017 by guest http://jcm.asm.org/ Downloaded from 4 difficile was isolated. The isolate was then tested positively for both GDH and toxin A&B, 66 however GeneXpert C. diff was negative once again. A report was then issued as "isolation of 67 toxigenic C. difficile" and "direct cytotoxicity positive". Parasitological examinations, 68 rotavirus and adenovirus antigen detection gave negative results. 69
The patient was treated with metronidazole 500 mg/8h for 12 days but diarrhea persisted 70 although it was less intense, probably related to chronic pancreatitis. Abdominal ultrasound 71 and colonoscopy performed a few days later only showed diverticulosis. In following 72 microbiological examinations no C. difficile or other pathogens were isolated from stool. 73
The patient had only occasional contact with health care settings and his medical history did 74 not reflect antibiotic consumption. Although the toxigenic C. difficile was the only detected 75 pathogen, the diarrhea had not resolved after treatment and the clinical significance of C. 76 difficile in this particular case is unknown. 77
Strain characterization Because of the discrepancies in microbiological results, the C. difficile 78 isolate was further characterized. Several approaches were used to amplify parts of the toxin 79 genes. By means of a multiplex PCR to detect tcdA, tcdB, cdtA and cdtB (8, 9) positive results 80 were obtained only for tcdB gene. PCR amplification of tcdC was negative (10). These results 81 were further confirmed by PCRs covering the entire PaLoc as a part of toxinotyping scheme 82 (11). All three PCRs covering tcdA gene were negative and only B1 and B2 fragment covering 83 the tcdB gene were positive. Whole genome sequencing (genomic sequencing and analysis 84 was performed as described previously) (12) has finally clarified the structure of the PaLoc 85 region in this strain, and it represents a new toxinotype (XXXII) ( Figure 1A ). In this toxinotype 86 genes tcdR and tcdE are conserved. Also present is a complete tcdB gene, but several SNPs 87 were found in this region aligning to primers used for toxinotyping, explaining the negative 88 
